These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 28012426)
21. Neuromuscular blocking agents for adult patients with acute respiratory distress syndrome: A meta-analysis of randomized controlled trials. Tao W; Yang LQ; Gao J; Shao J J Trauma Acute Care Surg; 2018 Dec; 85(6):1102-1109. PubMed ID: 30462621 [TBL] [Abstract][Full Text] [Related]
22. Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome. Guervilly C; Bisbal M; Forel JM; Mechati M; Lehingue S; Bourenne J; Perrin G; Rambaud R; Adda M; Hraiech S; Marchi E; Roch A; Gainnier M; Papazian L Intensive Care Med; 2017 Mar; 43(3):408-418. PubMed ID: 28013329 [TBL] [Abstract][Full Text] [Related]
23. Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome. Gainnier M; Roch A; Forel JM; Thirion X; Arnal JM; Donati S; Papazian L Crit Care Med; 2004 Jan; 32(1):113-9. PubMed ID: 14707568 [TBL] [Abstract][Full Text] [Related]
24. Practice variability in management of acute respiratory distress syndrome: bringing evidence and clinician education to the bedside using a web-based teaching tool. Belda TE; Gajic O; Rabatin JT; Harrison BA Respir Care; 2004 Sep; 49(9):1015-21. PubMed ID: 15329172 [TBL] [Abstract][Full Text] [Related]
25. [Clinical study of early use of neuromuscular blocking agents in patients with severe sepsis and acute respiratory distress syndrome]. Lyu G; Wang X; Jiang W; Cai T; Zhang Y Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 May; 26(5):325-9. PubMed ID: 24809261 [TBL] [Abstract][Full Text] [Related]
26. Sedation and neuromuscular blocking agents in acute respiratory distress syndrome. Bourenne J; Hraiech S; Roch A; Gainnier M; Papazian L; Forel JM Ann Transl Med; 2017 Jul; 5(14):291. PubMed ID: 28828366 [TBL] [Abstract][Full Text] [Related]
27. Neuromuscular Blocking Agents for ARDS: A Systematic Review and Meta-Analysis. Torbic H; Krishnan S; Harnegie MP; Duggal A Respir Care; 2021 Jan; 66(1):120-128. PubMed ID: 32843506 [TBL] [Abstract][Full Text] [Related]
28. A Critical Care Clinician Survey Comparing Attitudes and Perceived Barriers to Low Tidal Volume Ventilation with Actual Practice. Weiss CH; Baker DW; Tulas K; Weiner S; Bechel M; Rademaker A; Fought A; Wunderink RG; Persell SD Ann Am Thorac Soc; 2017 Nov; 14(11):1682-1689. PubMed ID: 28771042 [TBL] [Abstract][Full Text] [Related]
29. A Markov computer simulation model of the economics of neuromuscular blockade in patients with acute respiratory distress syndrome. Macario A; Chow JL; Dexter F BMC Med Inform Decis Mak; 2006 Mar; 6():15. PubMed ID: 16539706 [TBL] [Abstract][Full Text] [Related]
30. Canadian survey of the use of sedatives, analgesics, and neuromuscular blocking agents in critically ill patients. Mehta S; Burry L; Fischer S; Martinez-Motta JC; Hallett D; Bowman D; Wong C; Meade MO; Stewart TE; Cook DJ; Crit Care Med; 2006 Feb; 34(2):374-80. PubMed ID: 16424717 [TBL] [Abstract][Full Text] [Related]
31. Barriers to low tidal volume ventilation in acute respiratory distress syndrome: survey development, validation, and results. Dennison CR; Mendez-Tellez PA; Wang W; Pronovost PJ; Needham DM Crit Care Med; 2007 Dec; 35(12):2747-54. PubMed ID: 17901838 [TBL] [Abstract][Full Text] [Related]
32. Best evidence in critical care medicine: The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome. Needham CJ; Brindley PG Can J Anaesth; 2012 Jan; 59(1):105-8. PubMed ID: 22042702 [TBL] [Abstract][Full Text] [Related]
33. Effects of the use of neuromuscular blocking agents on acute respiratory distress syndrome outcomes: A systematic review. Paramore S J Am Assoc Nurse Pract; 2018 Jun; 30(6):327-332. PubMed ID: 29878965 [TBL] [Abstract][Full Text] [Related]
34. Perceptions of diagnosis and management of patients with acute respiratory distress syndrome: a survey of United Kingdom intensive care physicians. Dushianthan A; Cusack R; Chee N; Dunn JO; Grocott MP BMC Anesthesiol; 2014; 14():87. PubMed ID: 25309125 [TBL] [Abstract][Full Text] [Related]
35. Continuous-infusion neuromuscular blocking agents in critically ill neonates and children. Johnson PN; Miller J; Gormley AK Pharmacotherapy; 2011 Jun; 31(6):609-20. PubMed ID: 21923445 [TBL] [Abstract][Full Text] [Related]
37. Neuromuscular Blocking Agent Use in Critical Care Transport Not Associated With Intubation. Esteves AM; Fjeld KJ; Yonan AS; Roginski MA Air Med J; 2024; 43(4):328-332. PubMed ID: 38897696 [TBL] [Abstract][Full Text] [Related]
38. Clinical and financial impact of pharmacy services in the intensive care unit: pharmacist and prescriber perceptions. MacLaren R; Brett McQueen R; Campbell J Pharmacotherapy; 2013 Apr; 33(4):401-10. PubMed ID: 23468188 [TBL] [Abstract][Full Text] [Related]
39. One-year experience with an acute respiratory distress syndrome standard operating procedure on intensive care unit. Luedike P; Totzeck M; Rammos C; Kindgen-Milles D; Kelm M; Rassaf T J Crit Care; 2015 Oct; 30(5):1114-8. PubMed ID: 26216357 [TBL] [Abstract][Full Text] [Related]
40. Survey of interventions for the prevention and treatment of acute respiratory distress syndrome. Meade MO; Jacka MJ; Cook DJ; Dodek P; Griffith L; Guyatt GH; Crit Care Med; 2004 Apr; 32(4):946-54. PubMed ID: 15071383 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]